Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumeet Salaniwal

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Physical Review Letters|December 18, 2002
Amorphous solidification in polymer-platelet nanocompositesSumeet Salaniwal, Sanat K Kumar, Jack F Douglas
Proteins|October 28, 2006
Critical evaluation of methods to incorporate entropy loss upon binding in high-throughput dockingSumeet Salaniwal, Eric S Manas, Juan C Alvarez, et al.
Journal of Computer-Aided Molecular Design|April 3, 2010
Using a homology model of cytochrome P450 2D6 to predict substrate site of metabolismRayomand J Unwalla, Jason B Cross, Sumeet Salaniwal, et al.
International Journal of Molecular Sciences|April 30, 2021
Development of a Robust High-Throughput Screening Platform for Inhibitors of the Striatal-Enriched Tyrosine Phosphatase (STEP)Lester J Lambert, Stefan Grotegut, Maria Celeridad, et al.
ACS Medicinal Chemistry Letters|December 23, 2014
Discovery of Sulfonamidebenzamides as Selective Apoptotic CHOP Pathway Activators of the Unfolded Protein ResponseDaniel P Flaherty, Justin R Miller, Danielle M Garshott, et al.
ACS Medicinal Chemistry Letters|March 11, 2014
Discovery of ML314, a Brain Penetrant Non-Peptidic β-Arrestin Biased Agonist of the Neurotensin NTR1 ReceptorSatyamaheshwar Peddibhotla, Michael P Hedrick, Paul Hershberger, et al.
Cancer Research|November 6, 2025
Enozertinib is a Selective, Brain-penetrant EGFR inhibitor for Treating Non-small Cell Lung Cancers with EGFR Exon 20 and Atypical MutationsMelissa R Junttila, Claire E Repellin, Sumeet Salaniwal, et al.
Journal of Medicinal Chemistry|October 26, 2025
Discovery of ORIC-533, an Orally Bioavailable CD73 Inhibitor That Maintains Activity in High AMP Environments to Reverse Tumor ImmunosuppressionJared T Moore, Hiroyuki Kawai, Brian R Blank, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Physical Review Letters|December 18, 2002
Amorphous solidification in polymer-platelet nanocompositesSumeet Salaniwal, Sanat K Kumar, Jack F Douglas
Proteins|October 28, 2006
Critical evaluation of methods to incorporate entropy loss upon binding in high-throughput dockingSumeet Salaniwal, Eric S Manas, Juan C Alvarez, et al.
Journal of Computer-Aided Molecular Design|April 3, 2010
Using a homology model of cytochrome P450 2D6 to predict substrate site of metabolismRayomand J Unwalla, Jason B Cross, Sumeet Salaniwal, et al.
International Journal of Molecular Sciences|April 30, 2021
Development of a Robust High-Throughput Screening Platform for Inhibitors of the Striatal-Enriched Tyrosine Phosphatase (STEP)Lester J Lambert, Stefan Grotegut, Maria Celeridad, et al.
ACS Medicinal Chemistry Letters|December 23, 2014
Discovery of Sulfonamidebenzamides as Selective Apoptotic CHOP Pathway Activators of the Unfolded Protein ResponseDaniel P Flaherty, Justin R Miller, Danielle M Garshott, et al.
ACS Medicinal Chemistry Letters|March 11, 2014
Discovery of ML314, a Brain Penetrant Non-Peptidic β-Arrestin Biased Agonist of the Neurotensin NTR1 ReceptorSatyamaheshwar Peddibhotla, Michael P Hedrick, Paul Hershberger, et al.
Cancer Research|November 6, 2025
Enozertinib is a Selective, Brain-penetrant EGFR inhibitor for Treating Non-small Cell Lung Cancers with EGFR Exon 20 and Atypical MutationsMelissa R Junttila, Claire E Repellin, Sumeet Salaniwal, et al.
Journal of Medicinal Chemistry|October 26, 2025
Discovery of ORIC-533, an Orally Bioavailable CD73 Inhibitor That Maintains Activity in High AMP Environments to Reverse Tumor ImmunosuppressionJared T Moore, Hiroyuki Kawai, Brian R Blank, et al.
Pageof 1